Skip to main content
. 2023 Dec 15;15:1270226. doi: 10.3389/fnagi.2023.1270226

Table 1.

Demographic and psychometric characteristics of participants.

HTT mutation carriers Healthy control
PreHD group P PreHC vs. HC EMHD group p EMHD vs. PreHD p EMHD vs. HC Combined PreHD & EMHD p HC vs. PreHD&EMHD
N 45 11 56 41
Age, years
(SE)
31.4
(1.1)
0.48 36.9
(2.9)
0.04 0.25 32.5
(1.1)
0.9 32.8
(1.7)
Male/female 19/26 0.6 8/3a 0.07 0.03 27/29 0.3 15/26
Education, years (SE) 14.4
(0.2)
0.13 14.3
(0.4)
0.9 0.25 14.4
(0.2)
0.1 14.8
(0.2)
CAG repeats
(SE)
43.26
(0.5)
46.8b
(1.5)
0.003 43.9
(0.5)
DBS
(SE)
231.1
(12.7)
386.4b
(37.9)
<0.001 261.6
(15.0)
FAS, words
(SE)
46.5
(2.0)
0.07 33.1a,b
(2.6)
0.004 <0.001 44.0a
(1.9)
0.006 51.5
(1.8)
LMWT
(SE)
5.8
(0.3)
0.23 4.7a,b
(0.4)
0.06 0.006 5.6
(0.2)
0.06 6.2
(0.2)
LMWT total score (SE) 38.6a
(1.3)
<0.001 33.4 a,b
(1.9)
0.03 <0.001 37.1a
(1.1)
<0.001 44.2
0.6
Pictures total score (SE) 35.4a
(0.6)
0.003 29.4a,b
(2.2)
<0.001 <0.001 34.5a
(0.6)
<0.001 38.0
(0.6)
MMSE
(SE)
28.8
(0.6)
0.07 27.1a,b
(0.8)
0.10 <0.001 28.2a
(0.5)
0.008 29.
(0.1)
STAI state score
(SE)
38.8
(1.4)
0.09 35.6
(3.4)
0.33 0.97 38.2
(1.3)
0.16 35.5
(1.4)
STAI trait score
(SE)
41.8
(1.7)
0.42 38.2
(4.1)
0.37 0.6 41.1
(1.6)
0.62 40.0
(1.4)
UHDRS-TMS
(SE)
1.3
(0.5)
0.011 18.5a,b
(2.7)
<0.001 <0.001 8.4a
(2.4)
0
SDMT
(SE)
45.6a
(3.1)
<0.001 27.6a,b
(2.9)
0.0005 <0.001 38.6a
(2.7)
<0.001 59.4
1.6
Stroop color naming (SE) 75.1
(3.7)
0.22 56.2a,b
(3.4)
0.001 <0.001 67.4a
(3.1)
0.003 80.3
(2.1)
Stroop word reading (SE) 86.5
(3.2)
0.14 70.3a,b
(4.8)
0.007 <0.001 80.3a
(3.0)
0.005 92.4
(2.3)
Stroop interference (SE) 42.8
(2.4)
0.63 34.9a,b
(2.3)
0.03 0.015 39.7
(1.8)
0.11 44.5
(2.5)
TFC
(SE)
13.0
0.00
12.2a,b
(0.3)
0.001 <0.0001 12.7a
(0.1)
0.04 13.0
0.00

Data are presented as the means and standard errors (SE). MMSE, Mini-Mental State Examination; LMWT, Luria Memory Words Test; FAS, Controlled Oral Word Association Test; SST, STAI, Spielberger State–Trait Anxiety Inventory, SDMT, Symbol Digit Modalities Test; TFC – total functional capacity.

a

significant differences p < 0.05 between healthy control and HTT mutation carriers.

b

significant differences p < 0.05 between PreHD individuals and EMHD patients.